Prevention of 6-hydroxydopamine-induced rotational behavior by BDNF somatic gene transfer

The Rat Brain in Stereotaxic Coordinates

Paxinos, G., & Watson, C. (1983) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 28,585

Production of High-Titer Recombinant Adeno-Associated Virus Vectors in the Absence of Helper Adenovirus

Xiao, X., Li, J., & Samulski, R. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.3.2224-2232.1998 · Cited by 1,381

Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain

Kaplitt, M. G., Leone, P., Samulski, R. J., Xiao, X., Pfaff, D. W., O’Malley, K. L., & During, M. J. (1994) · Nature Genetics · doi:10.1038/ng1094-148 · Cited by 1,031

Human and rat brain-derived neurotrophic factor and neurotrophin-3: Gene structures, distributions, and chromosomal localizations

Maisonpierre, P. C., Beau, M. M. L., Espinosa, R., Ip, N. Y., Belluscio, L., de la Monte, S. M., Squinto, S. P., Furth, M. E., & Yancopoulos, G. D. (1991) · Genomics · doi:10.1016/0888-7543(91)90436-i · Cited by 514

Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector

McCown, T. J., Xiao, X., Li, J., Breese, G. R., & Samulski, R. J. (1996) · Brain Research · doi:10.1016/0006-8993(95)01488-8 · Cited by 450

Transgenic mice expressing β-galactosidase in mature neurons under neuron-specific enolase promoter control

Forss‐Petter, S., Danielson, P. E., Catsicas, S., Battenberg, E., Price, J. A., Nerenberg, M. I., & Sutcliffe, G. (1990) · Neuron · doi:10.1016/0896-6273(90)90308-3 · Cited by 368

Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson’s disease in rats

Mandel, R. J., Spratt, S. K., Snyder, R. O., & Leff, S. E. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.14083 · Cited by 328

Efficient transduction of green fluorescent protein in spinal cord neurons using adeno-associated virus vectors containing cell type-specific promoters

Peel, A., Zolotukhin, S., Schrimsher, G. W., Muzyczka, N., & Reier, P. J. (1997) · Gene Therapy · doi:10.1038/sj.gt.3300358 · Cited by 289

Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo.

Altar, C. A., Boylan, C. B., Jackson, C., Hershenson, S., Miller, J., Wiegand, S. J., Lindsay, R. M., & Hyman, C. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.23.11347 · Cited by 275

Intrastriatal implantation of fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevents degeneration of dopaminergic neurons in a rat model of Parkinson’s disease

Levivier, M., Przedborski, S., Bencsics, C., & Kang, U. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-12-07810.1995 · Cited by 274

Functional Repression of cAMP Response Element in 6-Hydroxydopamine-treated Neuronal Cells

Chalovich, E. M., Zhu, J.-H., Caltagarone, J., Bowser, R., & Chu, C. T. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602632200 · Cited by 1,385

Brain-derived neurotrophic factor in the control human brain, and in Alzheimer’s disease and Parkinson’s disease

Murer, M. G., Yan, Q., & Raisman-Vozari, R. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00014-9 · Cited by 874

GDNF, NGF and BDNF as Therapeutic Options for Neurodegeneration

Allen, S. J., Watson, J. J., Shoemark, D. K., Barua, N. U., & Patel, N. K. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.004 · Cited by 820

BDNF as a Promising Therapeutic Agent in Parkinson’s Disease

Palasz, E., Wysocka, A., Gasiorowska, A., Chalimoniuk, M., Niewiadomski, W., & Niewiadomska, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031170 · Cited by 504

Gene therapy with brain-derived neurotrophic factor as a protection: Retinal ganglion cells in a rat glaucoma model

Martin, K. R. G., Quigley, H. A., Zack, D. J., Levkovitch-Verbin, H., Kielczewski, J., Valenta, D., Baumrind, L., Pease, M. E., Klein, R. L., & Hauswirth, W. W. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.02-1332 · Cited by 362

Effect of CNTF on retinal ganglion cell survival in experimental glaucoma

Pease, M. E., Zack, D. J., Berlinicke, C., Bloom, K., Cone, F., Wang, Y., Klein, R. L., Hauswirth, W. W., & Quigley, H. A. (2009) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-3013 · Cited by 222

Dopaminergic Cell Loss Induced by Human A30P α -Synuclein Gene Transfer to the Rat Substantia Nigra

Klein, R. L., King, M. A., Hamby, M. E., & Meyer, E. M. (2002) · Human Gene Therapy · doi:10.1089/10430340252837206 · Cited by 212

Recombinant AAV-mediated gene delivery to the central nervous system

Tenenbaum, L., Chtarto, A., Lehtonen, E., Velu, T. J., Brotchi, J., & Levivier, M. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.506 · Cited by 213

Exercise-induced brain-derived neurotrophic factor expression: Therapeutic implications for Alzheimer’s dementia

Wang, R., & Holsinger, R. M. D. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.10.002 · Cited by 203

Gene Therapy for Parkinson’s Disease, An Update

Axelsen, T. M., & Woldbye, D. P. D. (2018) · Journal of Parkinson s Disease · doi:10.3233/jpd-181331 · Cited by 185

Adeno-associated virus vectors: activity and applications in the CNS

Peel, A. L., & Klein, R. L. (2000) · Journal of Neuroscience Methods · doi:10.1016/s0165-0270(00)00183-7 · Cited by 155

Neurotrophic factor therapy for Parkinson’s disease

Rangasamy, S. B., Soderstrom, K. E., Bakay, R. A. E., & Kordower, J. H. (2010) · Progress in brain research · doi:10.1016/s0079-6123(10)84013-0 · Cited by 155

Comparison of the capability of GDNF, BDNF, or both, to protect nigrostriatal neurons in a rat model of Parkinson’s disease

Sun, M., Kong, L., Wang, X., Lu, X.-G., Gao, Q., & Geller, A. I. (2005) · Brain Research · doi:10.1016/j.brainres.2005.05.072 · Cited by 154

Amelioration of chronic neuropathic pain after partial nerve injury by adeno-associated viral (AAV) vector-mediated over-expression of BDNF in the rat spinal cord

Eaton, M. J., Blits, B., Ruitenberg, M. J., Verhaagen, J., & Oudega, M. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301814 · Cited by 146

Stimulation of the rat subthalamic nucleus is neuroprotective following significant nigral dopamine neuron loss

Spieles-Engemann, A. L., Behbehani, M. M., Collier, T. J., Wohlgenant, S. L., Steece‐Collier, K., Paumier, K. L., Daley, B. F., Gombash, S. E., Madhavan, L., Mandybur, G. T., et al. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.03.009 · Cited by 131

TrkB neurotrophic activities are blocked by α-synuclein, triggering dopaminergic cell death in Parkinson’s disease

Kang, S. S., Zhang, Z., Liu, X., Manfredsson, F. P., Benskey, M. J., Cao, X., Xu, J., Sun, Y. E., & Ye, K. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1713969114 · Cited by 131

Acupuncture prevents 6-hydroxydopamine-induced neuronal death in the nigrostriatal dopaminergic system in the rat Parkinson’s disease model

Park, H., Lim, S., Joo, W. S., Yin, C.-S., Lee, H., Lee, H., Seo, J.-C., Leem, K., Son, Y.-S., Kim, Y.-J., et al. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(02)00031-6 · Cited by 129

The Role of Astrocytes in the Neurorepair Process

Chiareli, R. A., Carvalho, G. A., Marques, B. L., Mota, L. S., Oliveira‐Lima, O. C., Gomes, R. M., Birbrair, A., Gomez, R. S., Simão, F., Klempin, F., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.665795 · Cited by 130

Viral vectors for neurotrophic factor delivery: A gene therapy approach for neurodegenerative diseases of the CNS

Seung Taik, L. I. M., Airavaara, M., & Harvey, B. K. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.10.002 · Cited by 128

LY503430, a Novel α-Amino-3-hydroxy-5-methylisoxazole-4-propionic Acid Receptor Potentiator with Functional, Neuroprotective and Neurotrophic Effects in Rodent Models of Parkinson’s Disease

Murray, T. K., Whalley, K., Robinson, C. S., Ward, M., Hicks, C. A., Lodge, D., Vandergriff, J. L., Baumbarger, P. J., Siuda, E. R., Gates, M. R., et al. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.049445 · Cited by 107

Bdnf gene is a downstream target of Nurr1 transcription factor in rat midbrain neurons in vitro

Volpicelli, F., Caiazzo, M., Greco, D., Consales, C., Leone, L., Perrone‐Capano, C., D’Amato, L. C., & di Porzio, U. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04494.x · Cited by 100

Recombinant AAV vectors containing the foot and mouth disease virus 2A sequence confer efficient bicistronic gene expression in cultured cells and rat substantia nigra neurons

Furler, S., Paterna, J. C., Weibel, M., & Büeler, H. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301469 · Cited by 103

Prokineticin-2 upregulation during neuronal injury mediates a compensatory protective response against dopaminergic neuronal degeneration

Gordon, R., Neal, M. P., Luo, J. D., Langley, M. R., Harischandra, D. S., Panicker, N., Charli, A., Jin, H., Anantharam, V., Woodruff, T. M., et al. (2016) · Nature Communications · doi:10.1038/ncomms12932 · Cited by 102

NGF gene transfer to intrinsic basal forebrain neurons increases cholinergic cell size and protects from age-related, spatial memory deficits in middle-aged rats

Klein, R. L., Hirko, A. C., Meyers, C., Grimes, J. R., Muzyczka, N., & Meyer, E. M. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02634-2 · Cited by 84

Adeno-associated viral vector-mediated gene transfer of brain-derived neurotrophic factor reverses atrophy of rubrospinal neurons following both acute and chronic spinal cord injury

Ruitenberg, M. J., Blits, B., Dijkhuizen, P. A., Beek, E. T. T., Bakker, A., van Heerikhuize, J. J., Pool, C. W., Hermens, W. T. J., Boer, G. J., & Verhaagen, J. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.11.018 · Cited by 80

PYM50028, a novel, orally active, nonpeptide neurotrophic factor inducer, prevents and reverses neuronal damage induced by MPP + in mesencephalic neurons and by MPTP in a mouse model of Parkinson's disease

Visanji, N. P., Orsi, A., Johnston, T. H., Howson, P. A., Dixon, K., Callizot, N., Brotchie, J. M., & Rees, D. D. (2008) · The FASEB Journal · doi:10.1096/fj.07-095398 · Cited by 78

Haploinsufficiency for trkB and trkC receptors induces cell loss and accumulation of α‐synuclein in the substantia nigra

Halbach, O. V. B. U., Minichiello, L., & Unsicker, K. (2005) · The FASEB Journal · doi:10.1096/fj.05-3845fje · Cited by 79

Neurotensin-polyplex-mediated brain-derived neurotrophic factor gene delivery into nigral dopamine neurons prevents nigrostriatal degeneration in a rat model of early Parkinson’s disease

Hernandez-Chan, N. G., Bannon, M. J., Orozco-Barrios, C. E., Escobedo, L., Zamudio, S., De la Cruz, F., Gongora-Alfaro, J. L., Armendáriz-Borunda, J., Reyes-Corona, D., Espadas-Alvarez, A. J., et al. (2015) · Journal of Biomedical Science · doi:10.1186/s12929-015-0166-7 · Cited by 73

Metformin regulates astrocyte reactivity in Parkinson's disease and normal aging

Ryu, Y., Go, J., Park, H., Choi, Y., Seo, Y. J., Choi, J. H., Rhee, M., Lee, T. G., Lee, C., & Kim, K. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108173 · Cited by 74

Adeno-associated viral vectors as agents for gene delivery: application in disorders and trauma of the central nervous system

Ruitenberg, M. J., Eggers, R., Boer, G. J., & Verhaagen, J. (2002) · Methods · doi:10.1016/s1046-2023(02)00222-0 · Cited by 75

Intracarotid Infusion of Mesenchymal Stem Cells in an Animal Model of Parkinson's Disease, Focusing on Cell Distribution and Neuroprotective and Behavioral Effects

Cerri, S., Greco, R., Levandis, G., Ghezzi, C., Mangione, A. S., Armentero, M., Bonizzi, A., Avanzini, M. A., Maccario, R., & Blandini, F. (2015) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0023 · Cited by 72

rAAV-mediated nigral human parkin over-expression partially ameliorates motor deficits via enhanced dopamine neurotransmission in a rat model of Parkinson's disease

Manfredsson, F. P., Bürger, C., Sullivan, L. F., Muzyczka, N., Lewin, A. S., & Mandel, R. J. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.06.019 · Cited by 70

Electrical stimulation of the dorsal columns of the spinal cord for Parkinson's disease

Yadav, A. P., & Nicolelis, M. A. L. (2017) · Movement Disorders · doi:10.1002/mds.27033 · Cited by 69

Potential Therapeutic Effects of Neurotrophins for Acute and Chronic Neurological Diseases

Cai, J., Hua, F., Yuan, L., Tang, W., Lu, J., Yu, S., Wang, X., & Hu, Y. (2014) · BioMed Research International · doi:10.1155/2014/601084 · Cited by 66

Small molecule TrkB agonist deoxygedunin protects nigrostriatal dopaminergic neurons from 6-OHDA and MPTP induced neurotoxicity in rodents

Nie, S., Yan, X., Chen, G., Ma, K., Han, C., Guo, Z., Zhang, Z., Ye, K., & Cao, X. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.08.016 · Cited by 65

GDNF therapy for Parkinson’s disease

Hong, M. G. L., Mukhida, K., & Mendez, I. M. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.7.1125 · Cited by 64

Delayed transplantation of precursor cell‐derived astrocytes provides multiple benefits in a rat model of Parkinsons

Pröschel, C., Stripay, J. L., Shih, C., Munger, J. C., & Noble, M. (2014) · EMBO Molecular Medicine · doi:10.1002/emmm.201302878 · Cited by 65

Neurotrophic actions of the novel AMPA receptor potentiator, LY404187, in rodent models of Parkinson's disease

O’Neill, M. J., Murray, T. K., Whalley, K., Ward, M., Hicks, C. A., Woodhouse, S., Osborne, D. J., & Skolnick, P. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.12.023 · Cited by 62

Gene transfer of trophic factors and stem cell grafting as treatments for Parkinson’s disease

Dass, B., Olanow, C. W., & Kordower, J. H. (2006) · Neurology · doi:10.1212/wnl.66.10_suppl_4.s89 · Cited by 62

Long-Term Rescue of Rat Retinal Ganglion Cells and Visual Function by AAV-Mediated BDNF Expression after Acute Elevation of Intraocular Pressure

Ren, R., Li, Y., Liu, Z., Liu, K., & He, S. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-8484 · Cited by 60

Cytoprotective effects of growth factors: BDNF more potent than GDNF in an organotypic culture model of Parkinson's disease

Stahl, K., Mylonakou, M. N., Skare, Ø., Amiry-Moghaddam, M. R., & Torp, R. (2011) · Brain Research · doi:10.1016/j.brainres.2010.12.090 · Cited by 63

Autotransplantation of Bone Marrow-Derived Stem Cells as a Therapy for Neurodegenerative Diseases

Kan, I., Melamed, E., & Offen, D. (2007) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-68976-8_10 · Cited by 60

Maturation but not survival of dopaminergic nigrostriatal neurons is affected in developing and aging BDNF-deficient mice

Baker, S. A., Stanford, L. E., Brown, R. E., & Hagg, T. (2005) · Brain Research · doi:10.1016/j.brainres.2005.01.052 · Cited by 55

Brain‐derived neurotrophic factor prevents the nigrostriatal degeneration induced by human immunodeficiency virus‐1 glycoprotein 120 in vivo

Nosheny, R. L., Ahmed, F. A. K. M., Yakovlev, A. G., Meyer, E. M., Ren, K., Tessarollo, L., & Mocchetti, I. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05506.x · Cited by 53

Neurosteroid allopregnanolone attenuates cognitive dysfunctions in 6-OHDA-induced rat model of Parkinson’s disease

Nezhadi, A., Sheibani, V., Esmaeilpour, K., Shabani, M., & Esmaeili‐Mahani, S. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.03.019 · Cited by 52

Behavioural and immunohistochemical changes following supranigral administration of sonic hedgehog in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmosets

Dass, B., Iravani, M. M., Jackson, M. J., Engber, T. M., Galdes, A., & Jenner, P. G. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00214-2 · Cited by 52

Adeno-Associated Virus Vectors for Therapeutic Gene Transfer

Stilwell, J. L., & Samulski, R. J. (2003) · BioTechniques · doi:10.2144/03341dd01 · Cited by 52

BDNF inhibits neurodegenerative disease–associated asparaginyl endopeptidase activity via phosphorylation by AKT

Wang, Z.-H., Wu, W., Kang, S. S., Liu, X., Wu, Z., Peng, J., Yu, S. P., Manfredsson, F. P., Sandoval, I. M., Liu, X., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.99007 · Cited by 52

Regulation of BDNF transcription by Nrf2 and MeCP2 ameliorates MPTP-induced neurotoxicity

Cao, Q., Zou, Q., Zhao, X. Y., Zhang, Y., Qu, Y., Wang, N., Murayama, S., Qi, Q., Hashimoto, K., Lin, S., et al. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01063-9 · Cited by 47

Localization of nerve growth factor, neurotrophin-3, and glial cell line-derived neurotrophic factor in nestin-expressing reactive astrocytes in the caudate-putamen of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated C57/Bl mice

Chen, L.-W., Zhang, J., Shum, D. K., & Chan, Y. (2006) · The Journal of Comparative Neurology · doi:10.1002/cne.21014 · Cited by 47

Chronic Spinal Cord Electrical Stimulation Protects Against 6-hydroxydopamine Lesions

Yadav, A. P., Fuentes, R., Zhang, H., Vinholo, T., Wang, C.-H., Freire, M., & Nicolelis, M. (2014) · Scientific Reports · doi:10.1038/srep03839 · Cited by 43

Production and Application of Multicistronic Constructs for Various Human Disease Therapies

Shaimardanova, A. A., Chulpanova, D. S., Kitaeva, K. V., Abdrakhmanova, I. I., Chernov, V. M., Rutland, C. S., Rizvanov, A. A., & Solovyeva, V. V. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11110580 · Cited by 45

Treating Parkinson's Disease via Activation of BDNF/TrkB Signaling Pathways and Inhibition of Delta-Secretase

Kang, S. S., Wu, Z., Liu, X., Edgington‐Mitchell, L. E., & Ye, K. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01248-1 · Cited by 45

Expression of full-length and truncated trkB in human striatum and substantia nigra neurons: implications for Parkinson’s disease

Fenner, M. E., Achim, C. L., & Fenner, B. M. (2013) · Journal of Molecular Histology · doi:10.1007/s10735-013-9562-z · Cited by 42

Adeno‐associated virus‐mediated gene delivery approaches for the treatment of CNS disorders

Terzi, D., & Zachariou, V. (2008) · Biotechnology Journal · doi:10.1002/biot.200800284 · Cited by 43

Brain-derived neurotrophic factor as a prototype neuroprotective factor against HIV-1-associated neuronal degeneration

Nosheny, R. L., Mocchetti, I., & Bachis, A. (2005) · Neurotoxicity Research · doi:10.1007/bf03033829 · Cited by 41

In Vivo Gene Transfer to Dopamine Neurons of Rat Substantia Nigra via the High-Affinity Neurotensin Receptor

Álvarez-Maya, I., Navarro-Quiroga, I., Meraz‐Ríos, M. A., Aceves, J., & Martínez‐Fong, D. (2001) · Molecular Medicine · doi:10.1007/bf03401952 · Cited by 41

Advances in the delivery of treatments for Parkinson’s disease

Johnston, T. H., Fox, S. H., & Brotchie, J. M. (2005) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2.6.1059 · Cited by 41

Use of growth factors for the treatment of Parkinson’s disease

Yasuda, T., & Mochizuki, H. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.55 · Cited by 41

Neuroprotective effect of BDNF in young and aged 6-OHDA treated rat model of Parkinson disease.

Singh, S. T., Ahmad, R., Mathur, D., Sagar, R., & Krishana, B. (2006) · PubMed · Cited by 36

Therapeutic Potential of Repeated Intravenous Transplantation of Human Adipose-Derived Stem Cells in Subchronic MPTP-Induced Parkinson’s Disease Mouse Model

Park, H., & Chang, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218129 · Cited by 34

A Single Domain Shark Antibody Targeting the Transferrin Receptor 1 Delivers a TrkB Agonist Antibody to the Brain and Provides Full Neuroprotection in a Mouse Model of Parkinson’s Disease

Clarke, E., Stocki, P., Sinclair, E. H., Gauhar, A., Fletcher, E. J. R., Krawczun-Rygmaczewska, A., Duty, S., Walsh, F. S., Doherty, P., & Rutkowski, J. L. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14071335 · Cited by 32

Identification of brain-derived neurotrophic factor in nestin-expressing astroglial cells in the neostriatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice

Chen, L.-W., Hu, H., Liu, L., Yung, K. K. L., & Chan, Y. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.04.020 · Cited by 31

Gene Therapy for Parkinson's Disease

Denyer, R., & Douglas, M. R. (2012) · Parkinson s Disease · doi:10.1155/2012/757305 · Cited by 31

Brain‐Derived Neurotrophic Factor Prevents Human Immunodeficiency Virus Type 1 Protein gp120 Neurotoxicity in the Rat Nigrostriatal System

Mocchetti, I., Nosheny, R. L., Tanda, G., Ren, K., & Meyer, E. M. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1403.010 · Cited by 30

Decreased expression of ErbB4 and tyrosine hydroxylase mRNA and protein in the ventral midbrain of aged rats

Dickerson, J. W., Hemmerle, A. M., Numan, S., Lundgren, K. H., & Seroogy, K. B. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.06.008 · Cited by 29

Live Attenuated Vaccine Based on Duck Enteritis Virus against Duck Hepatitis A Virus Types 1 and 3

Zou, Z., Ma, J., Huang, K. L., Chen, H., Liu, Z., & Jin, M. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01613 · Cited by 29

Recombinant adeno-associated virus vector design and gene expression in the mammalian brain

Paterna, J., & Büeler, H. (2002) · Methods · doi:10.1016/s1046-2023(02)00225-6 · Cited by 29

Electro-Acupuncture Ameliorated MPTP-Induced Parkinsonism in Mice via TrkB Neurotrophic Signaling

Zhao, Y., Luo, D., Ning, Z., Rong, J., & Lao, L. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00496 · Cited by 27

Chemokine receptors and neurotrophic factors: Potential therapy against aids dementia?

Mocchetti, I., Bachis, A., & Masliah, E. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21492 · Cited by 27

Sonic hedgehog delivered by an adeno-associated virus protects dopaminergic neurones against 6-OHDA toxicity in the rat

Dass, B., Iravani, M. M., Huang, C.-S., Barsoum, J., Engber, T. M., Galdes, A., & Jenner, P. G. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0227-7 · Cited by 26

Developmental Expression of Neurotrophins and Their Receptors in Postnatal Rat Ventral Midbrain

Numan, S., Gall, C. M., & Seroogy, K. B. (2005) · Journal of Molecular Neuroscience · doi:10.1385/jmn:27:2:245 · Cited by 25

Prospects for the treatment of Parkinson’s disease using neurotrophic factors

Hurelbrink, C. B., & Barker, R. A. (2001) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2.10.1531 · Cited by 25

A Novel Peptide Delivers Plasmids across Blood-Brain Barrier into Neuronal Cells as a Single-Component Transfer Vector

Fu, A., Zhang, M., Gao, F., Xu, X., & Chen, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059642 · Cited by 28

Neurotrophins as Therapeutic Agents for Parkinson’s Disease; New Chances From Focused Ultrasound?

Stefani, A., Pierantozzi, M., Cardarelli, S., Stefani, L., Cerroni, R., Conti, M., Garasto, E., Mercuri, N. B., Marini, C., & Sucapane, P. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.846681 · Cited by 23

Fingolimod (FTY720) is not protective in the subacute MPTP mouse model of Parkinson's disease and does not lead to a sustainable increase of brain‐derived neurotrophic factor

Komnig, D., Dagli, T. C., Habib, P., Zeyen, T., Schulz, J. B., & Falkenburger, B. H. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14575 · Cited by 24

Brain-derived neurotrophic factor expression in the substantia nigra does not change after lesions of dopaminergic neurons

Mocchetti, I., Bachis, A., Nosheny, R. L., & Tanda, G. (2007) · Neurotoxicity Research · doi:10.1007/bf03033922 · Cited by 25

Implementing Neuronal Plasticity in NeuroAIDS: the Experience of Brain-derived Neurotrophic Factor and other Neurotrophic Factors

Mocchetti, I., Bachis, A., Campbell, L. A., & Avdoshina, V. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9488-y · Cited by 23

CGP 56999A, a GABAB receptor antagonist, enhances expression of brain-derived neurotrophic factor and attenuates dopamine depletion in the rat corpus striatum following a 6-hydroxydopamine lesion of the nigrostriatal pathway

Enna, S. J., Reisman, S. A., & Stanford, J. A. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.07.004 · Cited by 21

Neurotrophic factors for the treatment of Parkinson's disease

Chiocco, M. J., Harvey, B. K., Wang, Y., & Hoffer, B. J. (2007) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(08)70024-5 · Cited by 20

Gene delivery with viral vectors for cerebrovascular diseases

Gan, Y. (2012) · Frontiers in Bioscience-Elite · doi:10.2741/e607 · Cited by 20

Microecologics and Exercise: Targeting the Microbiota–Gut–Brain Axis for Central Nervous System Disease Intervention

Peng, Z., Hou, T., Yang, K., Zhang, J., Mao, Y.-H., & Hou, X. (2025) · Nutrients · doi:10.3390/nu17111769 · Cited by 21

Expression of BDNF-Associated lncRNAs in Parkinson’s disease

Akbari, M., Gholipour, M., Hussen, B. M., Taheri, M. N., Eslami, S., Sayad, A., & Ghafouri‐Fard, S. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-00946-1 · Cited by 19

Preclinical development of gene therapy for Parkinson's disease

Porras, G., & Bézard, E. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.08.003 · Cited by 19

Gene therapy for Parkinson's disease

Lawlor, P. A., & During, M. J. (2004) · Expert Reviews in Molecular Medicine · doi:10.1017/s146239940400746x · Cited by 18

Are growth factors the answer?

Ramaswamy, S., & Kordower, J. H. (2009) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(09)70809-0 · Cited by 17

Bidirectional changes in water-maze learning following recombinant adenovirus-associated viral vector (rAAV)-mediated brain-derived neurotrophic factor expression in the rat hippocampus

Pietropaolo, S., Paterna, J., Büeler, H., Feldon, J., & Yee, B. K. (2007) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3282da0bf6 · Cited by 15

Neurotrophic Support of Midbrain Dopaminergic Neurons

Halbach, O. V. B. U., & Unsicker, K. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-0322-8_7 · Cited by 15

Protective mechanisms by glial cell line-derived neurotrophic factor and cerebral dopamine neurotrophic factor against the α-synuclein accumulation in Parkinson's disease

Er, Ş., & Airavaara, M. (2023) · Biochemical Society Transactions · doi:10.1042/bst20220770 · Cited by 14

Gene therapy in Parkinson?s disease

Eberhardt, O., & Schulz, J. B. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0947-x · Cited by 14

Pre- and post-synaptic modification by neurotrophins

Kojima, M., Klein, R. L., & Hatanaka, H. (2002) · Neuroscience Research · doi:10.1016/s0168-0102(02)00034-2 · Cited by 13

Gene therapy approaches for the treatment of Parkinson's disease

DASS, B., & Kordower, J. H. (2007) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)84045-0 · Cited by 11

Adeno-associated virus vector-mediated gene transfer to somatic cells in the central nervous system

Klein, R. L., Mandel, R. J., & Muzyczka, N. (2000) · Advances in virus research · doi:10.1016/s0065-3527(00)55015-5 · Cited by 11

Gazing into the future: Parkinson's disease gene therapeutics to modify natural history

Maguire‐Zeiss, K. A., Mhyre, T. R., & Federoff, H. J. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.09.030 · Cited by 11

Intranasal AdipoRon mitigates motor and cognitive deficits in hemiparkinsonian rats through neuroprotective mechanisms against oxidative stress and synaptic dysfunction

Alimohammadi, S., Mohaddes, G., Keyhanmanesh, ‬., Athari, S. Z., Azizifar, N., & Farajdokht, F. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110180 · Cited by 10

Neuroreplacement, Growth Factor, and Small Molecule Neurotrophic Approaches for Treating Parkinson's Disease

O’Neill, M. J., Messenger, M. J., Lakics, V., Murray, T. K., Karran, E. H., Szekeres, P. G., Nisenbaum, E. S., & Merchant, K. (2006) · International review of neurobiology · doi:10.1016/s0074-7742(06)77006-4 · Cited by 10

Can cinnamon bring aroma in Parkinson′s disease treatment?

Pahan, P., & Pahan, K. (2015) · Neural Regeneration Research · doi:10.4103/1673-5374.150647 · Cited by 10

Pharmacological approaches to disease-modifying therapies in Parkinson’s disease

O’Neill, M. J., & Siemers, E. (2002) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2.6.819 · Cited by 10

Gene Therapy for the Treatment of Parkinson’s Disease: The Nature of the Biologics Expands the Future Indications

Fiandaca, M. S., Bankiewicz, K. S., & Federoff, H. J. (2012) · Pharmaceuticals · doi:10.3390/ph5060553 · Cited by 10

Application of adeno-associated viral vectors in behavioral research

Nair, H. P., & Young, L. J. (2002) · Methods · doi:10.1016/s1046-2023(02)00223-2 · Cited by 8

Adenoviral vector-mediated GDNF gene therapy in a rodent lesion model of late stage Parkinson's disease

Lapchak, P. A., Araujo, D. M., Hilt, D. C., Sheng, J., & Jiao, S. (1997) · Brain Research · doi:10.1016/s0006-8993(97)01100-1 · Cited by 97

A Single Intramesencephalic Injection of Brain-Derived Neurotrophic Factor Induces Persistent Rotational Asymmetry in Rats

Shults, C. W., Matthews, R. T., Altar, C. A., Hill, L. R., & Langlais, P. J. (1994) · Experimental Neurology · doi:10.1006/exnr.1994.1023 · Cited by 30

Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo.

Altar, C. A., Boylan, C. B., Jackson, C., Hershenson, S., Miller, J., Wiegand, S. J., Lindsay, R. M., & Hyman, C. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.23.11347 · Cited by 275

Delivery of a GDNF Gene into the Substantia Nigra after a Progressive 6-OHDA Lesion Maintains Functional Nigrostriatal Connections

Kozlowski, D. A., Connor, B. J., Tillerson, J. L., Schallert, T. J., & Bohn, M. C. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7463 · Cited by 108

Efficacy of Brain‐Derived Neurotrophic Factor and Neurotrophin‐3 on Neurochemical and Behavioral Deficits Associated with Partial Nigrostriatal Dopamine Lesions

Altar, C. A., Boylan, C. B., Fritsche, M., Jones, B. E., Jackson, C., Wiegand, S. J., Lindsay, R. M., & Hyman, C. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63031021.x · Cited by 138